Institutional Ownership
4d Molecular Therapeutics In
CUSIP 35104E100COMFDMTQ1 2026
Institutional Holders
149
13F filers
Shares Held
50.60M
Aggregate institutional
Institutional Value
$469.39M
Q1 2026
Net New Holders
-2
24 new · 26 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions24
Increased39
Decreased48
Sold out26
Institutional Holders
149 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Janus Henderson Group PLC | 5.25M | $48.87M | +611.3K | Added |
| 2 | Ra Capital Management, L.P. | 5.05M | $47.01M | −603.4K | Reduced |
| 3 | Goldman Sachs Group Inc | 4.21M | $39.15M | −97.5K | Reduced |
| 4 | Blackrock, Inc. | 4.15M | $38.59M | +80.4K | Added |
| 5 | Novo Holdings A/S | 3.65M | $33.99M | 0 | Held |
| 6 | Bvf Inc/Il | 2.88M | $26.81M | −1.75M | Reduced |
| 7 | State Street Corp | 2.71M | $25.21M | +19.0K | Added |
| 8 | Vanguard Capital Management LLC | 2.20M | $20.44M | +2.20M | First Filing |
| 9 | Armistice Capital, LLC | 2.00M | $18.62M | +64.0K | Added |
| 10 | Adage Capital Partners Gp, L.L.C. | 1.61M | $14.94M | +370.0K | Added |
139 more institutional holders on Premium
See every fund holding 4d Molecular Therapeutics In, with full quarter-over-quarter share changes.
Unlock all holders